Table 2 Estimates of infected and not infected subjects, of costs to be sustained and of the reduction in the number of infections: comparison between current situation (no treatment) and the two PC strategies considered
| Â | Total infected | Not infected | Costs | Â DELTA: reduction in infected individuals (=Â recovered subjects) |
|---|---|---|---|---|
No treatment | Â | Â | Â | Â |
Children | 37 500 | 212 500 | Â | Â |
Adults | 135 000 | 365 000 | Â | Â |
Total | 172 500 | 577 500 | Â | Â |
| Â | Â | Â | Â | DELTA: PC targeting both SAC and adults vs no treatment |
PC targeting both SAC and adults |  | Reduction in infected individuals (= recovered subjects) | ||
Children | 11 700 | 238 300 | 29 750 | 25 800 |
Adults | 65 340 | 434 660 | 240 000 | 69 660 |
Total | 77 040 | 672 960 | 269 750 | 95 460 |
| Â | Â | Â | Â | DELTA: PC targeting SAC only vs no treatment |
PC targeting SAC only |  | Reduction in infected individuals (= recovered subjects) | ||
Children | 11 700 | 238 300 | 29 750 | 25 800 |
Adults | 135 000 | 365 000 | 0 | 0 |
Total | 146 700 | 603 300 | 29 750 | 25 800 |